LINDSEY ANDREOLI: Open Payments
NPI 1821498023 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 32 payments from 13 companies in 2025. Trend: 2023 $956 · 2024 $162 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $195 |
| ABBVIE INC. | 7 | $154 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| PFIZER INC. | 3 | $73 |
| Amgen Inc. | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Novo Nordisk Inc | 2 | $49 |
| ViiV Healthcare Company | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Seqirus USA Inc | 1 | $23 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, NURTEC ODT, NEXIUM, OTEZLA, TRELEGY ELLIPTA, QULIPTA.
Industry payments across CO — which companies pay providers there.
